BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1733751)

  • 1. Treatment of intractable childhood epilepsy with high-dose valproate.
    Ohtsuka Y; Amano R; Mizukawa M; Oka E; Ohtahara S
    Epilepsia; 1992; 33(1):158-64. PubMed ID: 1733751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of antiepileptic drug in childhood epilepsy: evaluation of the differences between epileptic syndromes.
    Konishi T; Naganuma Y; Hongo K; Murakami M; Yagi S; Yamatani M; Okada T
    Jpn J Psychiatry Neurol; 1994 Jun; 48(2):239-44. PubMed ID: 7807738
    [No Abstract]   [Full Text] [Related]  

  • 3. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pharmacokinetic observations on sodium valproate - a 5-year follow-up study in 100 children with epilepsy.
    Henriksen O; Johannessen SI
    Acta Neurol Scand; 1982 May; 65(5):504-23. PubMed ID: 6810648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin in intractable childhood epilepsy: a retrospective study.
    Gibbs JM; Appleton RE; Rosenbloom L
    Pediatr Neurol; 1992; 8(5):338-40. PubMed ID: 1418176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of refractory idiopathic epilepsies.
    Perucca E
    Epilepsia; 2001; 42 Suppl 3():31-5. PubMed ID: 11520320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aggravation of epilepsy by valproate sodium in a child with cryptogenic localization-related epilepsy].
    Watanabe Y; Watanabe K; Ohtsuka Y
    No To Hattatsu; 2011 Jan; 43(1):51-5. PubMed ID: 21400933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Idiopathic epilepsy with generalized seizures in early childhood].
    Gross-Selbeck G
    Monatsschr Kinderheilkd; 1992 Aug; 140(8):451-6. PubMed ID: 1435803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium valproate monotherapy in childhood epilepsy.
    Dulac O; Steru D; Rey E; Perret A; Arthuis M
    Brain Dev; 1986; 8(1):47-52. PubMed ID: 3085530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of generalized epilepsies of childhood and adolescence with sodium valproate ("epilim").
    Jeavons PM; Clark JE; Maheshwari MC
    Dev Med Child Neurol; 1977 Feb; 19(1):9-25. PubMed ID: 403104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational treatment of refractory epilepsy in childhood.
    Ohtsuka Y; Ogino T; Amano R; Yamatogi Y; Oka E; Ohtahara S
    Jpn J Psychiatry Neurol; 1988 Sep; 42(3):443-7. PubMed ID: 3149360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate monotherapy in children.
    Murphy JV
    Am J Med; 1988 Jan; 84(1A):17-22. PubMed ID: 3146220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose sodium valproate therapy for childhood refractory epilepsy.
    Amano R; Mizukawa M; Ohtsuka Y; Ohtahara S
    Jpn J Psychiatry Neurol; 1990 Jun; 44(2):343-4. PubMed ID: 2124287
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiepileptic drug treatment of West syndrome.
    Ito M
    Epilepsia; 1998; 39 Suppl 5():38-41. PubMed ID: 9737443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable outcome of epileptic blindness in children.
    Shahar E; Barak S
    J Child Neurol; 2003 Jan; 18(1):12-6. PubMed ID: 12661932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic issues and treatment of cryptogenic or symptomatic generalized epilepsies.
    Ohtsuka Y; Yoshinaga H; Kobayashi K; Ogino T; Oka M; Ito M
    Epilepsy Res; 2006 Aug; 70 Suppl 1():S132-40. PubMed ID: 16815681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment termination in children with idiopathic generalized epilepsy and cryptogenic focal epilepsy].
    Szwed-Białozyt B; Marszał E
    Przegl Lek; 2003; 60 Suppl 1():5-9. PubMed ID: 12945154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monotherapy with valproate in primary generalized epilepsies.
    Bourgeois B; Beaumanoir A; Blajev B; de la Cruz N; Despland PA; Egli M; Geudelin B; Kaspar U; Ketz E; Kronauer C
    Epilepsia; 1987; 28 Suppl 2():S8-11. PubMed ID: 3121293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate for drug-resistant epilepsies.
    Yeung S; Ferrie CD; Murdoch-Eaton DG; Livingston JH
    Eur J Paediatr Neurol; 2000; 4(1):31-3. PubMed ID: 10701102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.